SAREPTA THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
SAREPTA THERAPEUTICS, INC. (SRPT) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $1.83 million as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-10-31
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.83M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $3.28M.
- 2014-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $946.00K.
- 2014-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.86M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $1.83M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $3.28M 10-Q · filed 2018-08-08 |
| 2014-09-30 | $946.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.86M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.79M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |